Cargando…

CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition

BACKGROUND: Circular RNAs (circRNAs) are a class of non-coding RNA that play critical roles in the development and pathogenesis of various cancers. The circRNA circGSK3B (hsa_circ_0003763) has been shown to enhance cell proliferation, migration, and invasion in hepatocellular carcinoma. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xianxiong, Chen, Hengyu, Li, Lei, Yang, Feng, Wu, Chuanqing, Tao, Kaixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524915/
https://www.ncbi.nlm.nih.gov/pubmed/34666800
http://dx.doi.org/10.1186/s13046-021-02136-w
_version_ 1784585571339862016
author Ma, Xianxiong
Chen, Hengyu
Li, Lei
Yang, Feng
Wu, Chuanqing
Tao, Kaixiong
author_facet Ma, Xianxiong
Chen, Hengyu
Li, Lei
Yang, Feng
Wu, Chuanqing
Tao, Kaixiong
author_sort Ma, Xianxiong
collection PubMed
description BACKGROUND: Circular RNAs (circRNAs) are a class of non-coding RNA that play critical roles in the development and pathogenesis of various cancers. The circRNA circGSK3B (hsa_circ_0003763) has been shown to enhance cell proliferation, migration, and invasion in hepatocellular carcinoma. However, the specific functions and underlying mechanistic involvement of circGSK3B in gastric cancer (GC) have not yet been explored. Our study aimed to investigate the effect of circGSK3B on the progression of GC and to identify any potential mechanisms underlying this process. METHODS: CircRNA datasets associated with GC were obtained from the PubMed, GEO, and ArrayExpress databases, and circRNAs were validated via RT-qPCR and Sanger sequencing. Biotin-labeled RNA pull-down, mass spectrometry, RNA immunoprecipitation, and in vitro binding assays were employed to determine proteins demonstrating interactions with circGSK3B. Gene expression regulation was assessed through RT-qPCR, chromatin immunoprecipitation, and western blot assays. Gain- and loss-of-function assays were used to analyze any effects of circGSK3B and its partner regulatory molecule (EZH2) on the proliferation, invasion, and migration abilities of GC cells both in vitro and in vivo. RESULTS: CircGSK3B was mainly identified in the nucleus. This circRNA was present at a reduced concentration in GC tissues and cell lines. Overexpression of circGSK3B was shown to inhibit the growth, invasion, and metastasis of GC cells both in vitro and in vivo. Mechanistically, circGSK3B directly interacted with EZH2, acting to suppress the binding of EZH2 and H3K27me3 to the RORA promoter, and leading to an elevation in RORA expression and ultimately the suppression of GC progression. CONCLUSIONS: CircGSK3B acts as a tumor suppressor, reducing EZH2 trans-inhibition and GC progression. This demonstrates the potential use of this RNA as a therapeutic target for GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02136-w.
format Online
Article
Text
id pubmed-8524915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85249152021-10-22 CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition Ma, Xianxiong Chen, Hengyu Li, Lei Yang, Feng Wu, Chuanqing Tao, Kaixiong J Exp Clin Cancer Res Research BACKGROUND: Circular RNAs (circRNAs) are a class of non-coding RNA that play critical roles in the development and pathogenesis of various cancers. The circRNA circGSK3B (hsa_circ_0003763) has been shown to enhance cell proliferation, migration, and invasion in hepatocellular carcinoma. However, the specific functions and underlying mechanistic involvement of circGSK3B in gastric cancer (GC) have not yet been explored. Our study aimed to investigate the effect of circGSK3B on the progression of GC and to identify any potential mechanisms underlying this process. METHODS: CircRNA datasets associated with GC were obtained from the PubMed, GEO, and ArrayExpress databases, and circRNAs were validated via RT-qPCR and Sanger sequencing. Biotin-labeled RNA pull-down, mass spectrometry, RNA immunoprecipitation, and in vitro binding assays were employed to determine proteins demonstrating interactions with circGSK3B. Gene expression regulation was assessed through RT-qPCR, chromatin immunoprecipitation, and western blot assays. Gain- and loss-of-function assays were used to analyze any effects of circGSK3B and its partner regulatory molecule (EZH2) on the proliferation, invasion, and migration abilities of GC cells both in vitro and in vivo. RESULTS: CircGSK3B was mainly identified in the nucleus. This circRNA was present at a reduced concentration in GC tissues and cell lines. Overexpression of circGSK3B was shown to inhibit the growth, invasion, and metastasis of GC cells both in vitro and in vivo. Mechanistically, circGSK3B directly interacted with EZH2, acting to suppress the binding of EZH2 and H3K27me3 to the RORA promoter, and leading to an elevation in RORA expression and ultimately the suppression of GC progression. CONCLUSIONS: CircGSK3B acts as a tumor suppressor, reducing EZH2 trans-inhibition and GC progression. This demonstrates the potential use of this RNA as a therapeutic target for GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02136-w. BioMed Central 2021-10-19 /pmc/articles/PMC8524915/ /pubmed/34666800 http://dx.doi.org/10.1186/s13046-021-02136-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ma, Xianxiong
Chen, Hengyu
Li, Lei
Yang, Feng
Wu, Chuanqing
Tao, Kaixiong
CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
title CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
title_full CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
title_fullStr CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
title_full_unstemmed CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
title_short CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
title_sort circgsk3b promotes rora expression and suppresses gastric cancer progression through the prevention of ezh2 trans-inhibition
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524915/
https://www.ncbi.nlm.nih.gov/pubmed/34666800
http://dx.doi.org/10.1186/s13046-021-02136-w
work_keys_str_mv AT maxianxiong circgsk3bpromotesroraexpressionandsuppressesgastriccancerprogressionthroughthepreventionofezh2transinhibition
AT chenhengyu circgsk3bpromotesroraexpressionandsuppressesgastriccancerprogressionthroughthepreventionofezh2transinhibition
AT lilei circgsk3bpromotesroraexpressionandsuppressesgastriccancerprogressionthroughthepreventionofezh2transinhibition
AT yangfeng circgsk3bpromotesroraexpressionandsuppressesgastriccancerprogressionthroughthepreventionofezh2transinhibition
AT wuchuanqing circgsk3bpromotesroraexpressionandsuppressesgastriccancerprogressionthroughthepreventionofezh2transinhibition
AT taokaixiong circgsk3bpromotesroraexpressionandsuppressesgastriccancerprogressionthroughthepreventionofezh2transinhibition